ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors

SAN DIEGO & SINGAPORE--(BUSINESS WIRE)--ImmunoScape has raised $14M in new financing from Anzu Partners, Amgen Ventures, and EDBI to advance its therapeutic candidates toward the clinic

Click to view original post